High prevalence of Arginine to Glutamine Substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians

Table 1 Clinical features exhibited by hypertrophic cardiomyopathy (HCM) patients

Baseline characteristics	(n = 101)
Age, years	49 ± 10
Sex, males,%	62
NYHA class III, IV (%)	29
Dyspnea,%	65
Angina Pectoris,%	54
Syncope,%	33
LVESD, mm	20.3 ± 3.7
LVEDD, mm	36 ± 6.8
Septum, mm	21.2 ± 4.2
Abnormal ECG,%	62
Family history of HCM,%	37
Family history of SCD,%	32
Left ventricular outflow obstruction	49

NYHA - New York Heart Association; LVESD - Left ventricular end systolic dimension; LVEDD - Left ventricular end diastolic dimension; ECG - Electrocardiogram; HCM - Hypertrophic cardiomyopathy; SCD – Sudden cardiac death.

ISSN: 1471-2350